| 标题 |
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; et al 出版日期:2019/02/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)